Nairo Quintana again denies using tramadol as CAS confirms Tour de France disqualification

 Nairo Quintana (Arkea-Samsic) during stage 18 of the 2022 Tour de France
Nairo Quintana (Arkea-Samsic) during stage 18 of the 2022 Tour de France (Image credit: Michael Steele/Getty Images)

Nairo Quintana has continued to deny wrongdoing in his initial response to news that the Court of Arbitration of Sport had upheld the UCI’s decision to disqualify him from the 2022 Tour de France following his positive tests for the painkiller tramadol during the race.

The CAS verdict was announced on Thursday morning, ending Quintana’s hopes of having his 6th place finish at this year’s Tour restored. Quintana will not face a ban, as a first positive test for tramadol is considered an offence under the UCI Medical Rules but it does not constitute an anti-doping rule violation.

Barry Ryan
Head of Features

Barry Ryan is Head of Features at Cyclingnews. He has covered professional cycling since 2010, reporting from the Tour de France, Giro d’Italia and events from Argentina to Japan. His writing has appeared in The Independent, Procycling and Cycling Plus. He is the author of The Ascent: Sean Kelly, Stephen Roche and the Rise of Irish Cycling’s Golden Generation, published by Gill Books.